BIVALIRUDIN VERSUS UNFRACTIONED HEPARIN: DIFFERENTIAL BENEFIT ACROSS THE SPECTRUM OF PATIENTS RECEIVING PERCUTANEOUS CORONARY INTERVENTION FOR ACUTE CORONARY SYNDROMES

被引：0
|
作者：
Farag, Mohamed
Gorog, Diana
Srinivasan, Manivannan
机构：
[1] East & North Hertfordshire NHS Trust, Dept Cardiol, Stevenage, Herts, England
[2] Univ Hertfordshire, Postgrad Med Sch, Hatfield AL10 9AB, Herts, England
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2015年 / 65卷 / 10期
关键词：
D O I：
10.1016/S0735-1097(15)60118-8
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1139-097
引用
收藏
页码：A118 / A118
页数：1
相关论文
共 50 条
  • [1] BIVALIRUDIN VERSUS UNFRACTIONED HEPARIN IN PATIENTS RECEIVING PERCUTANEOUS CORONARY INTERVENTION FOR ACUTE CORONARY SYNDROMES
    Farag, Mohamed
    Gorog, Diana
    Srinivasan, Manivannan
    [J]. HEART, 2015, 101 : A9 - A9
  • [2] Bivalirudin versus unfractionated heparin: a meta-analysis of patients receiving percutaneous coronary intervention for acute coronary syndromes
    Farag, Mohamed
    Gorog, Diana A.
    Prasad, Abhiram
    Srinivasan, Manivannan
    [J]. OPEN HEART, 2015, 2 (01):
  • [3] Bivalirudin for percutaneous coronary intervention and in acute coronary syndromes
    Bates E.R.
    [J]. Current Cardiology Reports, 2001, 3 (5) : 348 - 354
  • [4] Heparin versus Bivalirudin in patients undergoing Percutaneous Coronary Intervention
    Rehmani, Ahmed
    Judkins, Chris
    Lee, Edmund
    Nguyen, Michael
    Whelan, Alan
    Schultz, Carl
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (11) : B135 - B135
  • [5] A meta-analysis of bivalirudin compared with unfractionated heparin in patients with acute coronary syndromes undergoing urgent percutaneous coronary intervention versus elective percutaneous coronary intervention
    Liu, Yulong
    Li, Liang
    Wang, Mei
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 70 (16) : C111 - C111
  • [6] Benefit of Bivalirudin Versus Heparin After Transradial and Transfemoral Percutaneous Coronary Intervention
    MacHaalany, Jimmy
    Abdelaal, Eltigani
    Bataille, Yoann
    Plourde, Guillaume
    Duranleau-Gagnon, Pierre
    Larose, Eric
    Dery, Jean-Pierre
    Barbeau, Gerald
    Rinfret, Stephane
    Rodes-Cabau, Josep
    De Larochelliere, Robert
    Roy, Louis
    Costerousse, Olivier
    Bertrand, Olivier F.
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2012, 110 (12): : 1742 - 1748
  • [7] Bivalirudin during percutaneous coronary intervention in acute coronary syndromes
    Laine, Marc
    Lemesle, Gilles
    Dabry, Thibaut
    Panagides, Vassili
    Peyrol, Michael
    Paganelli, Franck
    Bonello, Laurent
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2019, 20 (03) : 295 - 304
  • [8] Bivalirudin versus Unfractioned Heparin in Patients With Diabetes Mellitus Undergoing Elective Percutaneous Coronary Intervention: Results at One Year
    Li, Yulong
    Li, Jiawen
    Yang, Yuejin
    Yuan, Jinqing
    Zhao, Xueyan
    [J]. CIRCULATION, 2021, 144
  • [9] Bivalirudin Versus Heparin During Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction
    Patel, Hitcn
    Garris, Rana
    Bhutani, Suchit
    Shah, Priyank
    Rampal, Upamanyu
    Vasudev, Rahul
    Melki, Gabriel
    Abu Ghalyoun, Bader
    Virk, Hartaj
    Bikkina, Mahesh
    Shamoon, Faycz
    [J]. CARDIOLOGY RESEARCH, 2019, 10 (05) : 278 - 284
  • [10] Bivalirudin versus heparin with primary percutaneous coronary intervention
    Venetsanos, Dimitrios
    Lawesson, Ofia Sederholm
    James, Stefan
    Koul, Sasha
    Erlinge, David
    Swahn, Eva
    Alfredsson, Joakim
    [J]. AMERICAN HEART JOURNAL, 2018, 201 : 9 - 16
12345